FDG-PET Biomarker Ctte: Difference between revisions
Jump to navigation
Jump to search
| Line 21: | Line 21: | ||
==Reference Materials== | ==Reference Materials== | ||
*[[Media:Boellaard-Aanbevelingen NEDPAS 2007 - EN- 17032009.pdf|Dr Boellaard | *[[Media:Boellaard-Aanbevelingen NEDPAS 2007 - EN- 17032009.pdf|NL Standardization Protocol for Quantitative FDG-PET in multi-Center Trials - Dr Ronald Boellaard]] | ||
==Slide Presentations== | ==Slide Presentations== | ||
Revision as of 18:59, 2 June 2009
FDG-PET/CT Technical Committee Page
Mission; Foster adoption of ...
- pragmatic and cost effective standards for
- accurate and reproducible
- longitudinal
- quantitation of
- biologic parameters
- with clinical relevance
- and known sigma
FDG-PET/CT SubCommittees
- Covariates Rationale
- Digital Reference Objects
- Quality Control Metrics
- Quantitation Computation
- ROI Definition
- Software Version Tracking
Reference Materials
Slide Presentations
- QIBA Informational Meeting (Dec 1st at RSNA 2008) - Slide Content Review
- QIBA Working Meeting (Dec 4th at RSNA 2008) - FDG-PET/CT Breakout Session Slide Deck
- Fused Images
- Media:FDG-PET11-29.ppt
- QIBA FDG-PET/CT Mission Statement - 2009.03.10
- QIBA Profiling Process-03.31.2009 (Andrew Buckler, MS)